Biosignalmessvorrichtung

EP4732773 13. Februar 2025

Anmelder: OMRON Corporation, Omron Healthcare Co., Ltd. 🇯🇵

Details

Veröffentlichungs-Nr.
EP4732773
Anmeldetag
6. August 2024
Veröffentlichung
13. Februar 2025
Rechtsraum
EP
Offizieller Volltext

Abstract

To provide a biosignal measurement device that can achieve low power consumption while achieving highly accurate electrocardiographic measurement. The biosignal measurement device includes: a plurality of electrodes; a measurement unit including a detection circuit that detects a potential difference using the plurality of electrodes and configured to measure an electrocardiographic signal of a subject using the detection circuit; a battery configured to supply power to the detection circuit; and a selection unit configured to select a measurement electrode to be used for measurement of the electrocardiographic signal of the subject from the plurality of electrodes, based on the electrocardiographic signal of the subject, which is measured using at least some of the plurality of electrodes and the detection circuit. In addition, the measurement unit measures the electrocardiographic signal using the detection circuit and the measurement electrode.

Anmelder

Firmen
OMRON Corporation
Omron Healthcare Co., Ltd.
Land
🇯🇵 Japan
🇯🇵 Omron

Japanisches Technologieunternehmen mit Sitz in Kyoto. Omron entwickelt Automatisierungstechnik, Steuerungen, Sensoren und Robotik für die Industrie sowie elektronische Bauteile und medizintechnische Geräte.

1.838 Patente in unserer Datenbank

Vertreten von

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen